Plus therapeutics to present in-person at the h.c. wainwright 24th annual global investment conference

Austin, texas, sept. 08, 2022 (globe newswire) -- plus therapeutics, inc. (nasdaq: pstv), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, announced today that marc hedrick, m.d., president and chief executive officer, will present in-person at the h.c. wainwright 24th annual global investment conference on wednesday, september 14, 2022, at 2:00 p.m. et, and host investor meetings. the conference is being held at the lotte new york palace hotel in new york city.
PSTV Ratings Summary
PSTV Quant Ranking